Stocks
GlaxoSmithKline (GSK) Debt US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt, £ | 20 987 000 000 | 18 018 000 000 | 22 969 346 400 | 16 986 000 000 | 17 688 854 000 | 25 129 147 000 | |||
| Changes by years, y/y, % | 0% | -14% | +27% | -26% | +4% | -8.2% | |||
GlaxoSmithKline. Debt, £
GlaxoSmithKline. Debt, changes, %
GlaxoSmithKline (GSK) Debt US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt, £ | 23 791 104 000 | 23 781 053 900 | 23 895 938 000 | 17 688 854 000 | 25 129 147 000 | 25 129 147 000 | ||
| Changes by years, y/y, % | +34% | +40% | +49% | +4% | +6% | |||
| Changes by quarters, q/q, % | +40% | 0% | +0% | -26% | +42% | |||
